Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

Clinical trial NCT01103089 · COMPLETED

Trial details

NCT number: NCT01103089
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2010-03-01
Primary completion: 2010-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.